Final Line-Up for the Inaugural Health 2.0 Conference in Europe

6-7 April 2010, Paris, France.
Health 2.0 Europe will take place at the Cité Internationale Universitaire in Paris. This event will feature the three integral components of Health 2.0 in a rapid-fire live demo format where leading examples of Health 2.0 in North America will be compared and contextualized with the latest in European innovation. The three segments are:
  • Online Search and Content
  • Patient and Provider Communities
  • Consumer Self-Management Tools

Health 2.0 Europe will also examine the role of government in the spread of innovation and the impact of Health 2.0 on hospitals, payers and pharmaceutical companies. The confirmed prestigious speakers will be representing the following countries Germany, Switzerland, France, Italy, Spain, Great Britain, Ireland, Belgium, Hungary, Denmark, Sweden and the Netherlands.

Health 2.0 is also going to showcase the best of NEW European Health 2.0 companies in the Launch/Start-up Showcase.

Everyone will be invited to a dazzling reception at the famous Les Invalides, which has hosted royalty and emperors over the past 300 years.

All Health 2.0 Europe's speaking spots have now been filled but don't miss out on the opportunity to maximize your exposure by Exhibiting or Sponsoring. The deadline to become a sponsor is Monday, March 15th to get your logo in the program. Don't miss out on this opportunity for your organization to gain unparalleled exposure in front of the the most influential leaders in healthcare. Every sponsorship package includes logo placement on Health 2.0 website, marketing emails and conference materials. Join Health 2.0 distinguished sponsors, Pfizer, LEEM, Orange, Akamai, RAPP, Bayer, Publicis, Bupa, UCB, and LEEM to get your company in front of this distinguished audience.

Health 2.0 Europe's panels and topics include:

Keynote Addresses: The government view point - How does Health 2.0 fit into the various national IT strategies for EMRs, PHRs and national health and wellness?

Keynote Addresses from:

  • Etienne Caniard, French National Authority for Health France
  • Pieter Vos, Raad voor de Volksgezondheid en Zorg NL
  • Morten Elbæk Petersen, Denmark

Search & Content - How does the best of vertical search technology resonate in a world where government programs provide significant amounts of health content?

Demonstrations & case studies from:

  • Segolène Ayme, Orphanet EU
  • Frankie Dolan, MedWorm UK
  • Célia Boyer, Health On the Net Foundation Swiss
  • West Shell, Healthline Networks america
  • Steven Krein, Organized Wisdom america
  • Berci Mesko, Webicina Hungary

Patients and Online Communities - The advancement and popularity of patient communities online is an international phenomenon. We'll be examining communities in different cultures, languages and context, and see what impact they have on care delivery in different countries–and what the internationalization of information means for patients and doctors.

The patient perspective from:

  • Roberto Ascione, Italy
  • Gilles Frydman, ACOR america
  • Ben Heywood, PatientsLikeMe america
  • Neil Bacon, iWantGreatCare UK
  • Christian Angele, imedo Germany


  • Alexander Schachinger, Humboldt University Berlin Germany
  • Susannah Fox, Pew Internet america

Physicians and Online Communities - In the US, physician social networks are in some aspects replacing the function of traditional physician professional organizations. Physician activity online has a long tradition in Europe too. We’ll compare and contrast market approaches and results.

The physician perspective from:

  • Daniel Palestrant, Sermo america
  • Miguel Cabrer, Medting Spain
  • Tim Ringrose, UK
  • David Payne, British Medical Journal, Doc2Doc UK
  • Thomas Skoglund, Neurosurgic Sweden

Health 2.0 Tools - Consumer tools are an essential piece of the Health 2.0 landscape. Some of the most sophisticated drug, condition and treatment tools are giving patients as much if not more information than their physicians. Their use is already controversial in the US, but how is it playing out in different medical cultures across Europe?

  • Isabelle Adenot, French National Order of Pharmacists France
  • Roy Schoenberg, American Well america
  • David Doherty, 3G Doctor Ireland
  • Roni Zeiger, Google america
  • Sabine Pinedo, stichting Begeleide Zelfzorg (sBZ) NL
  • Neil Williams, Microsoft EU
  • Mohammad Al-Ubaydli, Patients Know Best UK
  • Joris Moolenaar, IPPZ NL
  • Sabine Donnai, Imperative Health UK
  • Alex Savic, Alensa AG Swiss

Hospitals, Payers and Health 2.0 - A look at how hospitals and payers are interacting with doctors and patients in the world of Health 2.0.

Demonstrations & commentary from:

  • Paul Hodgkin, PatientOpinion UK
  • Don Kemper, Healthwise america
  • Jean-Pascal Del Bano, Le Guide Santé France
  • Frank Neumann, BIG direkt gesund Germany
  • Emma Stanton, UK Department of Health UK

Pharma and Health 2.0 - How is Health 2.0 affecting Pharma? A look at how pharmaceutical companies are connecting with doctors and patients in new ways, and how Health 2.0 is changing the way they're conducting clinical research.

Discussion & case studies from:

  • Daniel Ghinn, Creation Interactive UK
  • Sylvie St-Laurent, Pfizer France
  • Len Starnes, Bayer Health Germany
  • Sophie Kune, ParleAvecElles France
  • René Hansen, UCB belgium
  • Gábor Gyarmati, Webbeteg Ltd. Hungary

Looking Ahead for Health 2.0 - Discoveries and lessons from the conference.

Discussion with:

  • Annabel Bentley, Bupa UK
  • Jean Louis Laporte, TribuCancer France
  • Elettra Ronchi, Organisation for Economic Co-operation and Development (OECD) Italy

Additional News & Information from Health 2.0:
Registration: Attendance rates will be increasing on Tuesday, March 16th. Every previous Health 2.0 conference has sold out - don't wait to secure your spot and register now.

For further information and registration, please visit:

About Health 2.0 Europe
Health 2.0 Europe is the premier conference dedicated to how Web 2.0 and social media are transforming healthcare systems in Europe. The conference brings together professionals in the converging industries of healthcare, the internet, mobile applications and social media. Health 2.0 Europe is organized by pioneering experts from Europe and the U.S. with decades of combined experience in health- and Web- related business and consulting, Matthew Holt and Indu Subaiya, founders of Health 2.0 in San Francisco, and Denise Silber, president of Basil Strategies in Paris. Please visit for more information.

Most Popular Now

Xenpozyme™ (olipudase alfa-rpcp) approved by FDA a…

The U.S. Food and Drug Administration (FDA) has approved Xenpozyme™ (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid...

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Research reveals widespread use of ineffective COV…

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

Efficacy, cash and more will increase booster shot…

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine (COMIRNATY® Original/Om...